Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cellular immunity in adult Hepatitis B-vaccinated serologic non-responders
2011-001943-60Phase 4Completed
- Sponsor
- Lars Jørgen Østergaard
- Start
- Jun 2011
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of hepatitis a vaccine + hepatitis b vaccine in hepatitis B (HBV) and hepatitis A (HAV), sponsored by Lars Jørgen Østergaard. Primary endpoint: HBsAg-specific CD4+ cell IFN-gamma response. Started Jun 2011; status: completed.
02
Drugs
hepatitis a vaccine + hepatitis b vaccine
03
Conditions
hepatitis B (HBV)hepatitis A (HAV)
Beyond the preview
Go deeper on 2011-001943-60.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001943-60.